PENGARUH SUPLEMENTASI PROBIOTIK DAN VITAMIN B1, B6, B12 TERHADAP PERUBAHAN KADAR IFN-γ DAN IL-12 PADA PASIEN TUBERKULOSIS DENGAN OBAT ANTI TUBERKULOSIS KATEGORI 1

Tuberculosis is an acute infectious disease that primarily affects the lungs. Probiotic supplementation proved to increase the number and activity of NK cell in peripheral blood by immunomodulation by IL-12, thus can increase IFN- γ production by Th1 response. Vitamin B1 acts on macrophages and a...

Full description

Saved in:
Bibliographic Details
Main Author: RAHMAWATI RAISING, 051415153011
Format: Theses and Dissertations NonPeerReviewed
Language:English
English
Published: 2017
Subjects:
Online Access:http://repository.unair.ac.id/63943/1/abstrak.pdf
http://repository.unair.ac.id/63943/2/RAHMAWATI%20RAISING%20051415153011%20-%20PENGARUH%20SUPLEMENTASI%20PROBIOTIK%20DAN%20VITAMIN%20B1%20B6%20B12%20%20IFN%20DAN%20IL12%20%282%29.pdf
http://repository.unair.ac.id/63943/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
Description
Summary:Tuberculosis is an acute infectious disease that primarily affects the lungs. Probiotic supplementation proved to increase the number and activity of NK cell in peripheral blood by immunomodulation by IL-12, thus can increase IFN- γ production by Th1 response. Vitamin B1 acts on macrophages and affects neutrophil motility. Vitamin B6 is associated with the release of cytokines and the responsiveness of NK cells, vitamin B12 affects to lymphocytes, T cell proliferation, CD4+ ratios, and NK cell activity. Objectives: This study aimed to analyze the effects of probiotics and vitamin B1, B6, B12 suplementation on IFN-γ and IL-12 levels in patients with TB infection during intensive phase therapy. Methods: This study was conducted on December 2016 to February 2017 at Universitas Airlangga Hospital and Community Health Centers in Surabaya. Patients were divided into two groups standard regimen group and treatment group with once daily supplementation of probiotics and vitamin B1, B6, B12. Primary outcomes were measured plasma IFN-γ and IL-12 levels before initiation of study, after one month and two months after treatment. Results: 22 patients were divided into two groups. Plasma IFN-γ levels in the control (p=0.445) and treatment group (p=0.241) increased in first month then decreased after second months. Plasma IL-12 levels in control (p=0.091) and treatment group (p=0.061) increased in first month then decreased after second months. Conclusion: Therapy of probiotics and vitamin B1, B6, B12 suplementation tend to increase plasma IFN-γ and IL-12 levels in the first month and decrease in the second month